Investigator at NIH
CAR T cell therapy for multiple myeloma. Dr. Kochenderfer was the first to develop anti-BCMA CAR T cells, and his work focuses totally on developing new CAR T-cell therapies and conducting clinical trials of CAR T-cell therapies.
years treating myeloma: 6
Number of Myeloma Patients Treated Annually: 100
Details & contact info
Dickran G. Kazandjian M.D. Center for Cancer Research National Cancer Institute Building 10 Room 10C101A
Bethesda, MD, United States, 20892
Send a message to James N. Kochenderfer, MD